{"id":"https://openalex.org/W2590894549","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.198","title":"Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC).","display_name":"Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC).","publication_year":2014,"publication_date":"2014-02-01","ids":{"openalex":"https://openalex.org/W2590894549","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.198","mag":"2590894549"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.4_suppl.198","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.198","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.4_suppl.198","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090778997","display_name":"Karen A. Autio","orcid":"https://orcid.org/0000-0003-0720-0390","observed_orcids":["https://orcid.org/0000-0003-0720-0390"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen A. Autio","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064910504","display_name":"Aseem Anand","orcid":"https://orcid.org/0000-0001-9452-6094","observed_orcids":["https://orcid.org/0000-0001-9452-6094"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aseem Anand","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047318865","display_name":"Rachel Krupa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Krupa","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112211811","display_name":"Jessica E. Louw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Louw","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109334482","display_name":"Zaina Arslan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zaina Arslan","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022442590","display_name":"Ryan Vance Dittamore","orcid":"https://orcid.org/0000-0003-2281-3232","observed_orcids":["https://orcid.org/0000-0003-2281-3232"]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Dittamore","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072850546","display_name":"Howard I. Scher","orcid":"https://orcid.org/0000-0002-6791-9324","observed_orcids":["https://orcid.org/0000-0002-6791-9324"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard I. Scher","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"4_suppl","first_page":"198","last_page":"198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.020899999886751175,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.9760000109672546},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9539999961853027},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/intrapatient-heterogeneity","display_name":"intrapatient heterogeneity","score":0.8259999752044678},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.5899999737739563},{"id":"https://openalex.org/keywords/targeted-therapy-biomarkers","display_name":"targeted therapy biomarkers","score":0.5709999799728394},{"id":"https://openalex.org/keywords/serial-blood-sampling","display_name":"serial blood sampling","score":0.4749999940395355},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.4339999854564667},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5410000085830688},{"id":"https://openalex.org/keywords/metastatic-sites","display_name":"metastatic sites","score":0.3009999990463257},{"id":"https://openalex.org/keywords/alkaline-phosphatase","display_name":"alkaline phosphatase","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8403160572052002},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.7946968078613281},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7382073402404785},{"id":"https://openalex.org/C20417620","wikidata":"https://www.wikidata.org/wiki/Q4140229","display_name":"Glutamate carboxypeptidase II","level":4,"score":0.6872125864028931},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.541691780090332},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.53882896900177},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4992537498474121},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.48454180359840393},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4647255539894104},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4136057496070862},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.370426207780838},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3506929874420166},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31692543625831604},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.25206857919692993},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.21500688791275024},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2033495008945465},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14838624000549316},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1256120502948761},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.4_suppl.198","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.198","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.4_suppl.198","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2591413736","https://openalex.org/W2900748922","https://openalex.org/W4366501437","https://openalex.org/W7033538485","https://openalex.org/W3217118277","https://openalex.org/W2791226314","https://openalex.org/W2898462860","https://openalex.org/W2965016242","https://openalex.org/W2769555163","https://openalex.org/W2345023278"],"abstract_inverted_index":{"198":[0],"Background:":[1],"Prostate-specific":[2],"membrane":[3],"antigen":[4],"(PSMA)":[5],"is":[6,340],"a":[7,22,199],"folate":[8],"hydrolase":[9],"expressed":[10,209],"on":[11,40,272,350],"the":[12,141,210,218,247,357],"surface":[13],"of":[14,64,197,201,203,246,260,278,291,298,306,325,332,344],"PC":[15],"cells":[16,43,204,327],"that":[17,335],"has":[18],"been":[19],"used":[20],"as":[21,91],"target":[23],"to":[24,36,49,158,173,207,230,269,354],"detect":[25,37],"disease":[26],"and":[27,32,89,119,161,328,330],"selectively":[28],"deliver":[29],"cytotoxic":[30],"agents":[31],"radionuclides.":[33],"The":[34,258,323],"ability":[35],"PSMA":[38,88,186,241,261,279,307,319,333],"levels":[39],"circulating":[41],"tumor":[42],"(CTCs)":[44],"may":[45],"identify":[46],"patients":[47,74],"likely":[48],"benefit":[50],"from":[51,73],"such":[52],"targeted":[53],"therapy.":[54,273],"Technology":[55],"developed":[56],"by":[57,183],"Epic":[58],"Sciences":[59],"utilizes":[60],"high":[61],"definition":[62],"imaging":[63],"plated":[65],"nucleated":[66],"cells.":[67],"Methods:":[68],"Blood":[69],"samples":[70,133,137,343],"were":[71,83,134,147],"obtained":[72],"(pts)":[75],"with":[76,127,131,180,194,222,236,251,302,337],"metastatic":[77,111],"castration-resistant":[78],"prostate":[79],"cancer":[80],"(mCRPC).":[81],"Cells":[82],"stained":[84],"for":[85,217],"CK,":[86],"CD45,":[87],"categorized":[90],"classic":[92,145,195,254,294],"CTC":[93,101,115,146,163,182,196,288,295,311],"(CK+,":[94,102],"CD45-,":[95,103],"intact/morphologically":[96],"distinct":[97],"nuclei)":[98],"or":[99],"apoptotic":[100,162,224,264,287],"morphology":[104],"suggesting":[105],"apoptosis).":[106],"Clinical":[107],"data":[108],"including":[109,129,176],"treatment,":[110,234],"sites,":[112],"Veridex":[113,184],"CellSearch":[114],"enumeration,":[116],"prostate-specific":[117],"antigen,":[118],"alkaline":[120],"phosphatase":[121],"was":[122,188,215,242,281],"collected.":[123],"Results:":[124],"Fourteen":[125],"pts":[126,151,166,178,192,220,250,285,345],"mCRPC,":[128],"eight":[130],"serial":[132],"analyzed":[135],"(33":[136],"in":[138,149,164,190,244,263,283,286,309,318],"total).":[139],"At":[140],"first":[142],"draw":[143],"(t1),":[144],"detected":[148,189,243],"13":[150],"(93%),":[152],"(median":[153,168,226],"two":[154],"cells/ml,":[155,170],"range":[156,171,228],"0":[157],"40":[159],"cells/ml)":[160],"14":[165],"(100%)":[167],"four":[169],"1":[172],"18":[174],"cells/ml),":[175],"six":[177],"(42%)":[179],"no":[181,252],"CellSearch.":[185],"expression":[187,262,280,308,320,334],"five":[191],"(36%)":[193],"which":[198],"median":[200],"32%":[202],"(range":[205],"5":[206],"100%)":[208],"antigen.":[211],"Similar":[212],"intra-patient":[213,303],"heterogeneity":[214,305],"seen":[216,282],"10":[219],"(71.4%)":[221],"PSMA+":[223,253],"CTCs":[225,255,265],"33.5%,":[227],"11":[229],"75%":[231],"cells).":[232],"During":[233],"often":[235],"more":[237],"complete":[238],"androgen":[239],"suppression,":[240],"3":[245],"8":[248],"(38%)":[249],"at":[256,300,346],"t1.":[257],"presence":[259],"did":[266],"not":[267],"appear":[268],"change":[270],"while":[271],"Conclusions:":[274],"A":[275],"larger":[276],"percentage":[277],"mCRPC":[284],"(10":[289],"out":[290,297],"14)":[292,299],"than":[293],"(5":[296],"t1,":[301],"cell":[304],"both":[310],"populations.":[312],"Serial":[313],"measures":[314],"suggest":[315],"dynamic":[316],"changes":[317],"over":[321],"time.":[322],"threshold":[324],"detectable":[326],"proportion":[329],"degree":[331],"associates":[336],"drug":[338],"sensitivity":[339],"unknown.":[341],"Larger":[342],"discrete":[347],"time":[348],"points":[349],"therapy":[351],"are":[352],"underway":[353],"further":[355],"elucidate":[356],"potential":[358],"clinical":[359],"relevance.":[360]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-03-03T00:00:00"}